Anemia management with epoetin beta in anemic patients with cancer receiving chemotherapy: Pananemia observational study on clinical practice.
Salvatore Del Prete(Federico II University Hospital), Raffaele Addeo(George Moore Community Clinic), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Vincenzo Montesarchio(CTO Hospital), M. Biglietto(Ospedale Antonio Cardarelli), L. Maiorino, Maria Matarese(Università Campus Bio-Medico), Franco Vito Piantedosi, Anna Sabia, Anna Illiano(University of Naples Federico II), Agata Pisano(University of Campania "Luigi Vanvitelli"), Clementina Savastano, M. Bianco, Antonio Febbraro(Fatebenefratelli Hospital), Bruno Vincenzi(Campus Bio Medico University Hospital), Danilo Rocco, G. R. Pistolese(Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona), Livio Leo
Cited by 0
Related Papers
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
|Journal of Clinical Oncology|2012|234
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
|Annals of Oncology|2009|205
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
|Journal of Clinical Oncology|2017|186
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
|Cancer Discovery|2020|183
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study
|The Journal of Clinical Endocrinology & Metabolism|2019|180